Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-02-11 @ 5:00 AM
Study NCT ID:
NCT04294667
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2020-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor:
UCB Biopharma SRL
Organization: